4
Changes in Ownership
BOSTON SCIENTIFIC CORP Filed Acc 0001225208-25-006986
EVP & Group Pres, Cardiology sold 50,000 shares at $104.63 ($5,231,670)
- EVP & Group Pres, Cardiology acquired 50,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Fitzgerald Joseph Michael · EVP & Group Pres, Cardiology
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +50,000 | $26.15 | $1,307,500 | 228,342 | D |
| 2025-08-01 | Sale : show line 2 in the form 10b5-1 | −50,000 | $104.63 | $5,231,670 | 178,342 | D |
| Open-market sales · 50,000 sh · avg $104.63 · $5,231,670 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-08-01 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −50,000 | 150,000 | D |
Loading xslF345X05/doc4.xml…